Randomized Phase II Trial of MIBG Versus MIBG, Vincristine, and Irinotecan Versus MIBG and Vorinostat for Patients With Relapsed or Refractory Neuroblastoma: A Report From NANT Consortium.

Randomized Phase II Trial of MIBG Versus MIBG, Vincristine, and Irinotecan Versus MIBG and Vorinostat for Patients With Relapsed or Refractory Neuroblastoma: A Report From NANT Consortium. J Clin Oncol. 2021 11 01; 39(31):3506-3514.

View in: PubMed

subject areas

3-Iodobenzylguanidine
Adolescent
Adult
Antineoplastic Combined Chemotherapy Protocols
Child
Child, Preschool
Drug Resistance, Neoplasm
Female
Follow-Up Studies
Humans
Infant
Male
Neoplasm Recurrence, Local
Neuroblastoma
Prognosis
Prospective Studies
Salvage Therapy
Survival Rate
Vincristine
Young Adult

authors with profiles

Susan L. Cohn